Novel Pharmacological Inhibitors for Bacterial Protein Toxins
Many medically relevant bacteria cause severe human and animal diseases because they produce and release protein toxins that target mammalian cells. Because the toxin-induced cell damage is the reason for the clinical symptoms, the targeted pharmacological inhibition of the cytotoxic mode of action...
Saved in:
| Main Author: | |
|---|---|
| Format: | Ebooks |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute,
2022.
|
| Subjects: | |
| Online Access: | Get Fulltext |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 01184 am a22001813u 4500 | ||
|---|---|---|---|
| 001 | oer_unej_658 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a BARTH,Holger |e author |
| 245 | 0 | 0 | |a Novel Pharmacological Inhibitors for Bacterial Protein Toxins |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute, |c 2022. | ||
| 500 | |a http://oer.library.unej.ac.id//index.php?p=show_detail&id=658 | ||
| 500 | |a 610 | ||
| 520 | |a Many medically relevant bacteria cause severe human and animal diseases because they produce and release protein toxins that target mammalian cells. Because the toxin-induced cell damage is the reason for the clinical symptoms, the targeted pharmacological inhibition of the cytotoxic mode of action of bacterial toxins should prevent or cure the respective toxin-associated disease. Toxin inhibitors might be beneficial when the toxin acts in the absence of the producing bacteria (e.g., food poisoning), but also in combination with antibiotics in infectious diseases when the toxin-producing bacteria are present. | ||
| 546 | |a en | ||
| 690 | |a Public Health | ||
| 690 | |a 610 | ||
| 655 | 7 | |a Text |2 local | |
| 856 | 4 | 1 | |u http://oer.library.unej.ac.id//index.php?p=show_detail&id=658 |z Get Fulltext |